Head-to-Head depression showdown: IV ketamine vs. nasal spray
NCT ID NCT06713616
Summary
This study compares two forms of ketamine treatment for people with depression that hasn't responded to standard antidepressants. Researchers will test whether an IV ketamine drip works as well as the FDA-approved nasal spray Spravato®. The trial will measure how much depression symptoms improve, how tolerable side effects are, and which treatment patients prefer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
Contact Phone: •••-•••-••••
-
Houston Center for Advanced Psychiatric Treatment
RECRUITINGBellaire, Texas, 77401, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LifeStance Health
RECRUITINGMoore, Oklahoma, 73160, United States
Contact Email: •••••@•••••
-
Mood Institute
RECRUITINGMilford, Connecticut, 06461, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48104, United States
Contact Phone: •••-•••-••••
-
Yale School of Medicine
RECRUITINGNew Haven, Connecticut, 06512, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.